Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 23.08.2021

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
23.08.21EQS Group - Whistleblowing deadline fast approaching445EQS Group's H121 results were strong, showing robust increases in revenue and its customer base. Following its Q321 acquisition of Business Keeper, EQS is now well positioned to capitalise on the time-limited...
► Artikel lesen
23.08.21Global Energy Ventures - MOU signed with HyEnergy Project partners332The memorandum of understanding (MOU) recently signed between GEV and the HyEnergy Project partners will potentially confirm the validity of GEV's own scoping study. The study highlighted the cost advantage...
► Artikel lesen
23.08.21Arena Hospitality - Eastward Ho!166Arena Hospitality has bucked travel industry despondency with the expectation of a 'strong' summer in Croatia, its longstanding profit driver, and confirmation of sustained targeted investment despite...
► Artikel lesen
23.08.21LXi REIT - Swift and accretive capital deployment246Less than two months after closing its most recent, c £100m (gross) upsized equity placing, LXi REIT has substantially deployed the equity proceeds in accretive acquisitions. Further assets are in solicitors'...
► Artikel lesen
23.08.21Shield Therapeutics - 2021 focus on Accrufer368Shield Therapeutics (STX) successfully launched its key asset, Accrufer (oral ferric maltol for iron deficiency), in the US market on 1 July, in line with previous guidance. The US commercialisation...
► Artikel lesen